help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BRIGHTLING, C. E.
Right arrow Articles by PAVORD, I. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BRIGHTLING, C. E.
Right arrow Articles by PAVORD, I. D.

Am. J. Respir. Crit. Care Med., Volume 162, Number 3, September 2000, 878-882

Induced Sputum Inflammatory Mediator Concentrations in Eosinophilic Bronchitis and Asthma

CHRISTOPHER E. BRIGHTLING, RICHARD WARD, GERRIT WOLTMANN, PETER BRADDING, JAMES R. SHELLER, RYSZARD DWORSKI, and IAN D. PAVORD

Glenfield Hospital, Leicester, United Kingdom; and Vanderbilt University School of Medicine, Nashville, Tennessee

Eosinophilic bronchitis is a common cause of chronic cough, which like asthma is characterized by sputum eosinophilia, but in contrast to asthma there is no variable airflow obstruction or airway hyperresponsiveness. Our hypothesis was that the differences in airway pathophysiology maybe due to less active airway inflammation in eosinophilic bronchitis, with reduced release of important effector mediators. We measured the concentration of various proinflammatory mediators in induced sputum cell-free supernatant in eight patients with eosinophilic bronchitis, 17 patients with asthma matched for sputum eosinophil count, and 10 normal subjects. Cysteinyl-leukotrienes (cys-LT) were measured by enzyme immunoassay, eosinophilic cationic protein (ECP) by fluoroimmunoassay, prostanoids (PGE2, PGD2, TXB2, and PGF2alpha ) by gas chromatography-negative ion chemical ionization-mass spectroscopy, and histamine by radioenzymic assay. The geometric mean sputum eosinophil count was similar in asthma (13.4%) and eosinophilic bronchitis (12.5%). Sputum cys-LT and ECP were a mean (95% CI) 1.6-fold (1.1, 2.5) and 6.4-fold (1.4, 28) higher in eosinophilic bronchitis and 1.9-fold (1.3, 2.9) and 7.7-fold (1.2, 46) higher in asthma compared with that in control subjects (geometric mean, 5.9 and 95 ng/ml, respectively). In eosinophilic bronchitis the mean concentration of sputum PGD2 (0.79 ng/ml) and histamine (168 ng/ml) were significantly higher than in asthma (mean absolute difference in PGD2 concentration, 0.47 ng/ml [95% CI, 0.19 to 0.74] and mean-fold difference in histamine concentration, 6.7 [95% CI 1.7 to 26]) and normal subjects (0.64 ng/ml [0.36 to 0.90] and 11-fold [3.3 to 36]), respectively. In conclusion, eosinophilic bronchitis is associated with active airway inflammation with increased release of vasoactive and bronchoconstrictor mediators.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
F. Hollins, D. Kaur, W. Yang, G. Cruse, R. Saunders, A. Sutcliffe, P. Berger, A. Ito, C. E. Brightling, and P. Bradding
Human Airway Smooth Muscle Promotes Human Lung Mast Cell Survival, Proliferation, and Constitutive Activation: Cooperative Roles for CADM1, Stem Cell Factor, and IL-6
J. Immunol., August 15, 2008; 181(4): 2772 - 2780.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
S. Siddiqui, F. Hollins, S. Saha, and C. E. Brightling
Inflammatory cell microlocalisation and airway dysfunction: cause and effect?
Eur. Respir. J., December 1, 2007; 30(6): 1043 - 1056.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
K. Maneechotesuwan, S. Essilfie-Quaye, S. A. Kharitonov, I. M. Adcock, and P. J. Barnes
Loss of Control of Asthma Following Inhaled Corticosteroid Withdrawal Is Associated With Increased Sputum Interleukin-8 and Neutrophils
Chest, July 1, 2007; 132(1): 98 - 105.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
L. Woodman, A. Sutcliffe, D. Kaur, M. Berry, P. Bradding, I. D. Pavord, and C. E. Brightling
Chemokine Concentrations and Mast Cell Chemotactic Activity in BAL Fluid in Patients With Eosinophilic Bronchitis and Asthma, and in Normal Control Subjects.
Chest, August 1, 2006; 130(2): 371 - 378.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
N. Kulkarni, N. Pierse, L. Rushton, and J. Grigg
Carbon in airway macrophages and lung function in children.
N. Engl. J. Med., July 6, 2006; 355(1): 21 - 30.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
R. H. Green, C. E. Brightling, S. McKenna, B. Hargadon, N. Neale, D. Parker, C. Ruse, I. P. Hall, and I. D. Pavord
Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness
Eur. Respir. J., June 1, 2006; 27(6): 1144 - 1151.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
T. D. Mickleborough, M. R. Lindley, A. A. Ionescu, and A. D. Fly
Protective Effect of Fish Oil Supplementation on Exercise-Induced Bronchoconstriction in Asthma
Chest, January 1, 2006; 129(1): 39 - 49.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
S-W Park, J-S Park, Y-M Lee, J-H Lee, A-S Jang, D-J Kim, Y Hwangbo, S-T Uh, Y-H Kim, and C-S Park
Differences in radiological/HRCT findings in eosinophilic bronchitis and asthma: implication for bronchial responsiveness
Thorax, January 1, 2006; 61(1): 41 - 47.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. E. Brightling
Chronic Cough Due to Nonasthmatic Eosinophilic Bronchitis: ACCP Evidence-Based Clinical Practice Guidelines
Chest, January 1, 2006; 129(1_suppl): 116S - 121S.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
C E Brightling, S McKenna, B Hargadon, S Birring, R Green, R Siva, M Berry, D Parker, W Monteiro, I D Pavord, et al.
Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease
Thorax, March 1, 2005; 60(3): 193 - 198.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
S S Birring, R B Patel, D Parker, S Mckenna, B Hargadon, W R Monteiro, J F Falconer Smith, and I D Pavord
Airway function and markers of airway inflammation in patients with treated hypothyroidism
Thorax, March 1, 2005; 60(3): 249 - 253.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
C E Brightling and I D Pavord
Location, location, location: microlocalisation of inflammatory cells and airway dysfunction
Thorax, September 1, 2004; 59(9): 734 - 735.
[Full Text] [PDF]

Home page
 ChestHome page
S.-W. Park, Y. M. Lee, A. S. Jang, J. H. Lee, Y. Hwangbo, D. J. Kim, and C.-S. Park
Development of Chronic Airway Obstruction in Patients With Eosinophilic Bronchitis: A Prospective Follow-up Study
Chest, June 1, 2004; 125(6): 1998 - 2004.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
G Bochenek, E Nizankowska, A Gielicz, M Swierczynska, and A Szczeklik
Plasma 9{alpha},11{beta}-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma
Thorax, June 1, 2004; 59(6): 459 - 464.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. Kanazawa, S. Nomura, and J. Yoshikawa
Role of Microvascular Permeability on Physiologic Differences in Asthma and Eosinophilic Bronchitis
Am. J. Respir. Crit. Care Med., May 15, 2004; 169(10): 1125 - 1130.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. S. Birring, D. Parker, C. E. Brightling, P. Bradding, A. J. Wardlaw, and I. D. Pavord
Induced Sputum Inflammatory Mediator Concentrations in Chronic Cough
Am. J. Respir. Crit. Care Med., January 1, 2004; 169(1): 15 - 19.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
A H Morice and J A Kastelik
Cough * 1: Chronic cough in adults
Thorax, October 1, 2003; 58(10): 901 - 907.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
C E Brightling, F A Symon, S S Birring, P Bradding, A J Wardlaw, and I D Pavord
Comparison of airway immunopathology of eosinophilic bronchitis and asthma
Thorax, June 1, 2003; 58(6): 528 - 532.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
T. J. Wetter, Z. Xiang, D. A. Sonetti, H. C. Haverkamp, A. J. Rice, A. A. Abbasi, K. C. Meyer, and J. A. Dempsey
Role of lung inflammatory mediators as a cause of exercise-induced arterial hypoxemia in young athletes
J Appl Physiol, July 1, 2002; 93(1): 116 - 126.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
C. E. Brightling, P. Bradding, F. A. Symon, S. T. Holgate, A. J. Wardlaw, and I. D. Pavord
Mast-Cell Infiltration of Airway Smooth Muscle in Asthma
N. Engl. J. Med., May 30, 2002; 346(22): 1699 - 1705.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
P G Gibson, M Fujimura, and A Niimi
Eosinophilic bronchitis: clinical manifestations and implications for treatment
Thorax, February 1, 2002; 57(2): 178 - 182.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Asthma, Airway Biology, and Allergic Rhinitis in AJRCCM 2000
Am. J. Respir. Crit. Care Med., November 1, 2001; 164(9): 1559 - 1580.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. D. BRANNAN, S. D. ANDERSON, K. GOMES, G. G. KING, H. KIM CHAN, and J. PAUL SEALE
Fexofenadine Decreases Sensitivity to and Montelukast Improves Recovery from Inhaled Mannitol
Am. J. Respir. Crit. Care Med., May 1, 2001; 163(6): 1420 - 1425.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2000 American Thoracic Society 		  Solid Organ Transplant for the Intensivist 2008